Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication-Reference-Cited by-同舟云学术

Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication

Published:2021-11-06 Issue:2 Volume:9 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Danion François¹²,Letscher-Bru Valérie³,Guitard Juliette⁴,Sitbon Karine⁵,Dellière Sarah⁶,Angoulvant Adela⁷⁸,Desoubeaux Guillaume⁹,Botterel Francoise¹⁰,Bellanger Anne-Pauline¹¹^ORCID,Gargala Gilles¹²,Uhel Fabrice¹³,Bougnoux Marie-Elisabeth¹⁴^ORCID,Gerber Victor¹⁵,Michel Justin¹⁶,Cornu Marjorie¹⁷¹⁸,Bretagne Stéphane⁵⁶,Lanternier Fanny⁵¹⁹,Merdji Hamid,Delabranche Xavier,Parrot Antoine,Voiriot Guillaume,Urbina Tomas,Mebazaa Alexandre,Chousterman Benjamin,El Kalioubie Ahmed,Six Sophie,Coulon Pauline,Sendid Boualem,Anguel Nadia,Damoisel Charles,Mussini Charlotte,Villate Alban,Navellou Jean-Christophe,Girault Christophe,Cassagne Carole,Augereau Olivier,Dromer Francoise,Garcia-Hermoso Dea,Lortholary Olivier,Alanio Alexandre,

Affiliation:

1. Université de Strasbourg, Hôpitaux Universitaires de Strasbourg, Service de Maladies Infectieuses et Tropicales, Strasbourg, France

2. Laboratoire d’ImmunoRhumatologie Moléculaire, INSERM Unité Mixte de Recherche_S 1109, Strasbourg, France

3. Université de Strasbourg, Hôpitaux Universitaires de Strasbourg, Laboratoire de Mycologie-Parasitologie, Strasbourg, France

4. Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, Paris, France

5. Institut Pasteur, CNRS, Université de Paris, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et des Antifongiques, Paris, France

6. Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Laboratoire de Mycologie-Parasitologie, Paris, France

7. Université Paris Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service des Maladies Infectieuses et Tropicales, Le Kremlin-Bicêtre, France

8. Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Centre National de Recherche Scientifique, AgroParisTech, GQE-Le Moulon, Gif-sur-Yvette, France

9. Centre Hospitalier Universitaire de Tours, Laboratoire de Mycologie-Parasitologie, Tours, France

10. Assistance Publique-Hôpitaux de Paris, CHU Henri-Mondor, Laboratoire de Mycologie-Parasitologie, Créteil, France

11. CHU de Besançon, Laboratoire de Mycologie-Parasitologie, Besançon, France

12. CHU de Rouen, Laboratoire de Mycologie-Parasitologie, Rouen, France

13. Assistance Publique-Hôpitaux de Paris, Hôpital Louis-Mourier, Service de Médecine Intensive et Réanimation, Département Médical Universitaire ESPRIT, Colombes, France

14. Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Laboratoire de Mycologie-Parasitologie, Paris, France

15. Hôpitaux Civils de Colmar, Service de Réanimation Médicale, Colmar, France

16. Université Aix Marseille, AP-HM, Hôpital de La Conception, Service Oto-Rhino-Laryngologie et Chirurgie Cervico-faciale, Marseille, France

17. Université de Lille, Inserm U1285, CHU Lille, Laboratoire Parasitologie-Mycologie

18. CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France

19. Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Service de Maladies Infectieuses et Tropicales, Paris, France

Abstract

Abstract We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofab566/41099223/ofab566.pdf

Reference13 articles.

1. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.;Koehler;Lancet Infect Dis,2021

2. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.;Rudramurthy;Mycoses,2021

3. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.;Buil;Eurosurveillance,2021

4. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium.;Donnelly;Clin Infect Dis,2020

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme;The Lancet Regional Health - Europe;2024-10

2. Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in France;Open Forum Infectious Diseases;2024-07-23

3. Severe mold fungal infections in critically ill patients with COVID-19;Future Microbiology;2024-05-31

4. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India;Clinical Microbiology and Infection;2023-12

5. Rapid detection of Mucorales based on recombinase polymerase amplification and real-time PCR;Frontiers in Microbiology;2023-10-20